Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation

Journal of Bone and Mineral Research

Volumn 28, Issue 6, 2013, Pages 1434-1445

  Cheng, Ying Hua ^a   Hooker, R Adam ^a   Nguyen, Khanh ^a   Gerard O'Riley, Rita ^a   Waning, David L ^a   Chitteti, Brahmananda R ^a   Meijome, Tomas E ^a   Chua, Hui Lin ^a   Plett, Artur P ^a   Orschell, Christie M ^a   Srour, Edward F ^a   Mayo, Lindsey D ^a   Pavalko, Fredrick M ^a   Bruzzaniti, Angela ^a,b   Kacena, Melissa A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

BONE FORMATION; MEGAKARYOCYTE; OSTEOBLASTS; PYK2

Indexed keywords

BETA1 INTEGRIN; FOCAL ADHESION KINASE 2; PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR GATA 1; VINCULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME REGULATION; FEMALE; GENETIC TRANSCRIPTION; IN VIVO STUDY; MEGAKARYOCYTE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FOCAL ADHESION KINASE 2; MEGAKARYOCYTES; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84878238896     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1876     Document Type: Article

References (48)

1. Thiele J, Kvasnicka HM, Fischer R., Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders-aids to diagnosis and classification. Ann Hematol. 1999; 78: 495-506.
2. Lennert K, Nagai K, Schwarze EW., Patho-anatomical features of the bone marrow. Clin Haematol. 1975; 4: 331-51.
3. Chagraoui H, Wendling F, Vainchenker W., Pathogenesis of myelofibrosis with myeloid metaplasia: insight from mouse models. Best Pract Res Clin Haematol. 2006; 19: 399-412.
4. Kacena MA, Ciovacco WA., Megakaryocyte-bone cell interactions. Adv Exp Med Biol. 2010; 658: 31-41.
5. Yan XQ, Lacey D, Fletcher F, Hartley C, McElroy P, Sun Y, Xia M, Mu S, Saris C, Hill D, Hawley RG, McNiece IK., Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood. 1995; 86: 4025-33.
6. Yan XQ, Lacey D, Hill D, Chen Y, Fletcher F, Hawley RG, McNiece IK., A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood. 1996; 88: 402-9.
7. Villeval JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA, Cramer EM, Vainchenker W, Wendling F., High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood. 1997; 90: 4369-83.
8. Frey BM, Rafii S, Crystal RG, Moore MA., Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis. Schweiz Med Wochenschr. 1998; 128: 1587-92.
9. Frey BM, Rafii S, Teterson M, Eaton D, Crystal RG, Moore MA., Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis. J Immunol. 1998; 160: 691-9.
10. Kacena MA, Shivdasani RA, Wilson K, Xi Y, Troiano N, Nazarian A, Gundberg CM, Bouxsein ML, Lorenzo JA, Horowitz MC., Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2. J Bone Miner Res. 2004; 19: 652-60.
11. Kacena MA, Gundberg CM, Nelson T, Horowitz MC., Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype. Bone. 2005; 36: 215-23.
12. Suva LJ, Hartman E, Dilley JD, Russell S, Akel NS, Skinner RA, Hogue WR, Budde U, Varughese KI, Kanaji T, Ware J., Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease. Am J Pathol. 2008; 172: 430-9.
13. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH., A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997; 16: 3965-73.
14. Dominici M, Rasini V, Bussolari R, Chen X, Hofmann TJ, Spano C, Bernabei D, Veronesi E, Bertoni F, Paolucci P, Conte P, Horwitz EM., Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood. 2009; 114: 2333-43.
15. Ciovacco WA, Goldberg CG, Taylor AF, Lemieux JM, Horowitz MC, Donahue HJ, Kacena MA., The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiation. Bone. 2009; 44: 80-6.
16. Ciovacco WA, Cheng YH, Horowitz MC, Kacena MA., Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation. J Cell Biochem. 2010; 109: 774-81.
17. Lemieux JM, Horowitz MC, Kacena MA., Involvement of integrins alpha(3)beta(1) and alpha(5)beta(1) and glycoprotein IIb in megakaryocyte- induced osteoblast proliferation. J Cell Biochem. 2010; 109: 927-32.
18. Miao D, Murant S, Scutt N, Genever P, Scutt A., Megakaryocyte-bone marrow stromal cell aggregates demonstrate increased colony formation and alkaline phosphatase expression in vitro. Tissue Eng. 2004; 10: 807-17.
19. McDevitt MA, Shivdasani RA, Fujiwara Y, Yang H, Orkin SH., A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci USA. 1997; 94: 6781-5.
20. Buckbinder L, Crawford DT, Qi H, Ke HZ, Olson LM, Long KR, Bonnette PC, Baumann AP, Hambor JE, Grasser WA 3rd, Pan LC, Owen TA, Luzzio MJ, Hulford CA, Gebhard DF, Paralkar VM, Simmons HA, Kath JC, Roberts WG, Smock SL, Guzman-Perez A, Brown TA, Li M., Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. Proc Natl Acad Sci USA. 2007; 104: 10619-24.
21. Horowitz MC, Fields A, DeMeo D, Qian HY, Bothwell AL, Trepman E., Expression and regulation of Ly-6 differentiation antigens by murine osteoblasts. Endocrinology. 1994; 135: 1032-43.
22. Wong GL, Cohn DV., Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. Proc Natl Acad Sci USA. 1975; 72: 3167-71.
23. Towler DA, St. Arnaud R., Use of cultured osteoblastic cells to identify and characterize transcriptional regulatory complexes. In:, Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. 2nd ed., vol. 2. San Diego, CA: Academic Press; 2002. p. 1503-27.
24. Cheng YH, Chitteti BR, Streicher DA, Morgan JA, Rodriguez-Rodriguez S, Carlesso N, Srour EF, Kacena MA., Impact of maturational status on the ability of osteoblasts to enhance the hematopoietic function of stem and progenitor cells. J Bone Miner Res. 2011; 26: 1111-21.
25. Simmons DJ, Kent GN, Jilka RL, Scott DM, Fallon M, Cohn DV., Formation of bone by isolated, cultured osteoblasts in millipore diffusion chambers. Calcif Tissue Int. 1982; 34: 291-4.
26. Jilka RL, Cohn DV., Role of phosphodiesterase in the parathormone- stimulated adenosine 3',5'-monophosphate response in bone cell populations enriched in osteoclasts and osteoblasts. Endocrinology. 1981; 109: 743-7.
27. Arai F, Nakamura Y, Gomei Y, Suda T., Characterization of the niche complex molecules in bone marrow. Exp Hematol. 2008; 36: S25.
28. Mayack SR, Wagers AJ., Osteolineage niche cells initiate hematopoietic stem cell mobilization. Blood. 2008; 112: 519-31.
29. Kacena MA, Nelson T, Clough ME, Lee SK, Lorenzo JA, Gundberg CM, Horowitz MC., Megakaryocyte-mediated inhibition of osteoclast development. Bone. 2006; 39: 991-9.
30. Drachman JG, Sabath DF, Fox NE, Kaushansky K., Thrombopoietin signal transduction in purified murine megakaryocytes. Blood. 1997; 89: 483-92.
31. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ., Rapidly forming apatitic mineral in an osteoblastic cell line (UMR106-01 BSP). J Biol Chem. 1995; 270: 9420-8.
32. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25: 1468-86.
33. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR., Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595-610.
34. Avraham H, Park SY, Schinkmann K, Avraham S., RAFTK/Pyk2-mediated cellular signalling. Cell Signal. 2000; 12: 123-33.
35. Duong LT, Rodan GA., Integrin-mediated signaling in the regulation of osteoclast adhesion and activation. Front Biosci. 1998; 3: d757-68.
36. Duong LT, Nakamura I, Lakkakorpi PT, Lipfert L, Bett AJ, Rodan GA., Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2. J Biol Chem. 2001; 276: 7484-92.
37. Lakkakorpi PT, Bett AJ, Lipfert L, Rodan GA, Duong le T., PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption. J Biol Chem. 2003; 278: 11502-12.
38. Wang Q, Xie Y, Du QS, Wu XJ, Feng X, Mei L, McDonald JM, Xiong WC., Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin. J Cell Biol. 2003; 160: 565-75.
39. Bruzzaniti A, Neff L, Sandoval A, Du L, Horne WC, Baron R., Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts. Mol Cell Biol. 2009; 29: 3644-56.
40. Gil-Henn H, Destaing O, Sims NA, Aoki K, Alles N, Neff L, Sanjay A, Bruzzaniti A, De Camilli P, Baron R, Schlessinger J., Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice. J Cell Biol. 2007; 178: 1053-64.
41. Schick PK, Wojenski CM, Bennett VD, Ivanova T., The synthesis and localization of alternatively spliced fibronectin EIIIB in resting and thrombin-treated megakaryocytes. Blood. 1996; 87: 1817-23.
42. Schick PK, Wojensk CM, Bennett V, Denisova L., Fibronectin isoforms in megakaryocytes. Stem Cells. 1996; 14 (Suppl 1): 212-9.
43. Schick PK, Walker J, Profeta B, Denisova L, Bennett V., Synthesis and secretion of von Willebrand factor and fibronectin in megakaryocytes at different phases of maturation. Arterioscler Thromb Vasc Biol. 1997; 17: 797-801.
44. Xiong W, Parsons JT., Induction of apoptosis after expression of PYK2, a tyrosine kinase structurally related to focal adhesion kinase. J Cell Biol. 1997; 139: 529-39.
45. Kacena MA, Eleniste PP, Cheng YH, Huang S, Shivanna M, Meijome TE, Mayo LD, Bruzzaniti A., Megakaryocytes regulate expression of Pyk2 isoforms and caspase-mediated cleavage of actin in osteoblasts. J Biol Chem. 2012; 287: 17257-68.
46. Huang EJ, Nocka KH, Buck J, Besmer P., Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell. 1992; 3: 349-62.
47. Blair HC, Julian BA, Cao X, Jordan SE, Dong SS., Parathyroid hormone-regulated production of stem cell factor in human osteoblasts and osteoblast-like cells. Biochem Biophys Res Commun. 1999; 255: 778-84.
48. Blair HC, Dong SS, Julian BA., Expression of stem cell factor by osteoblasts in normal and hyperparathyroid bone: relation to ectopic mast cell differentiation. Virchows Arch. 1999; 435: 50-7.